Servier Bio-Innovation LLC

9 clinical trials · Sponsor

Record	Firm	Date
A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment (NCT07006688)	Servier Bio-Innovation LLC	2026-01-14
A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML (NCT06563804)	Servier Bio-Innovation LLC	2025-02-25
A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers. (NCT06116136)	Servier Bio-Innovation LLC	2024-08-31
Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT06162572)	Servier Bio-Innovation LLC	2024-08-07
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen (NCT06127407)	Servier Bio-Innovation LLC	2024-07-09
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP (NCT06188702)	Servier Bio-Innovation LLC	2024-04-29
Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma (NCT05921760)	Servier Bio-Innovation LLC	2023-10-23
A Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on the Pharmacokinetics of Vorasidenib in Healthy Subjects (NCT05843708)	Servier Bio-Innovation LLC	2023-04-14
A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid Tumors (NCT05159388)	Servier Bio-Innovation LLC	2021-09-08

Track Servier Bio-Innovation LLC automatically

Every clearance here is in the API, with alerts when new ones post.